You are currently viewing a new version of our website. To view the old version click .

Molecular and Cellular Mechanisms of Chronic Respiratory and Allergic Diseases

Topic Information

Dear Colleagues,

Chronic respiratory disorders, such as lung cancer, chronic obstructive pulmonary disease (COPD), lung fibrosis, asthma, or pulmonary hypertension (PH), are responsible for a significant portion of deaths worldwide. Likewise, allergic conditions other than asthma, for instance, allergic rhinitis, atopic dermatitis, or food allergy, lead to a substantial worsening of health-related quality of life in patients and considerable socio-economic burden to the affected families and healthcare systems. Various mechanisms and pathways, including those related to innate or adaptive immunity and/or immunometabolism or coagulation, underlie the pathogenesis of chronic diseases of the airways and allergic disorders. In recent decades, it has become apparent that the interaction between genetic background and beneficial (e.g., some diets) or adverse (e.g., pollution) environmental influences, frequently epigenetically mediated, plays a fundamental etiological role in the origins and progression of chronic lung and allergic diseases. Furthermore, current literature reports dysregulation of developmental pathways in chronic lung diseases and thereby suggests the importance of homeostatic mechanisms for lung structural and functional integrity in adult life. Other studies focus on the interactions between lung, skin, and gut microbiota, including bacteria, fungi, parasites, viruses, and archaea, and their influence on respiratory and allergic diseases. Despite considerable progress in our understanding of the mechanistic basis of those disorders achieved in recent years, a lot remains to be done to achieve substantial diagnostic and therapeutic advances in patient management. Therefore, the scope of this Topic focuses on recent findings in molecular and cellular pathogenesis, diagnostic methods, and treatment and prevention of chronic inflammatory lung and allergic diseases.

Prof. Dr. Malgorzata Wygrecka
Dr. Daniel P. Potaczek
Dr. Bilal Alashkar Alhamwe
Dr. Stefan Hadžić
Topic Editors

Keywords

  • allergic rhinitis
  • allergy
  • asthma
  • atopic dermatitis
  • chronic obstructive pulmonary disease (COPD)
  • coagulation
  • emphysema
  • epigenetics
  • epithelial–mesenchymal transition (EMT)
  • food allergy
  • idiopathic pulmonary fibrosis (IPF)
  • interstitial lung disease (ILD)
  • lung cancer
  • lung fibrosis
  • lung injury

Participating Journals

Allergies
Open Access
105 Articles
Launched in 2021
-Impact Factor
-CiteScore
35 DaysMedian Time to First Decision
-Highest JCR Category Ranking
BioChem
Open Access
105 Articles
Launched in 2021
-Impact Factor
-CiteScore
34 DaysMedian Time to First Decision
-Highest JCR Category Ranking
Biomedicines
Open Access
15,259 Articles
Launched in 2013
3.9Impact Factor
6.8CiteScore
17 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Cells
Open Access
19,453 Articles
Launched in 2012
5.2Impact Factor
10.5CiteScore
16 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Current Issues in Molecular Biology
Open Access
3,427 Articles
Launched in 1999
3.0Impact Factor
3.7CiteScore
18 DaysMedian Time to First Decision
Q3Highest JCR Category Ranking
Diagnostics
Open Access
16,656 Articles
Launched in 2011
3.3Impact Factor
5.9CiteScore
21 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
International Journal of Molecular Sciences
Open Access
104,704 Articles
Launched in 2000
4.9Impact Factor
9.0CiteScore
20 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking

Published Papers